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Abstract
Introduction: Exposure to high levels of endogenous estrogens is a main risk factor for breast cancer in women,
and in observational studies was found to be inversely associated with physical activity. The objective of the
present study is to determine the effect of physical activity interventions on sex hormone levels in healthy women.
Methods: Electronic databases (MEDLINE, EMBASE, CENTRAL), from inception to December 2014, and reference lists
of relevant reviews and clinical trials were searched, with no language restrictions applied. Randomized controlled
trials (RCTs) were included if they compared any type of exercise intervention to no intervention or other
interventions, and assessed the effects on estrogens, androgens or the sex hormone binding globulin (SHBG) in
cancer-free women. Following the method described in the Cochrane Handbook for Systematic Reviews of
Interventions, data on populations, interventions, and outcomes were extracted, and combined using the inverse-
variance method and a random-effects model. A pre-established protocol was drawn up, in which the primary
outcome was the difference in circulating estradiol concentrations between the physical activity (experimental) and
the control groups after intervention. Pre-specified subgroup analyses and sensitivity analysis according to the risk
of bias were conducted.
Results: Data suitable for quantitative synthesis were available from 18 RCTs (1994 participants) for total estradiol
and from 5 RCTs (1245 participants) for free estradiol. The overall effect of physical activity was a statistically
significant decrease of both total estradiol (standardized mean difference [SMD] -0.12; 95 % confidence interval [CI]
-0.20 to −0.03; P = 0.01; I2 = 0 %) and free estradiol (SMD −0.20; 95 % CI −0.31 to −0.09; P = 0.0005; I2 = 0 %).
Subgroup analyses suggest that this effect is independent of menopausal status and is more noticeable for non-
obese women and for high intensity exercise. Meta-analysis for secondary outcomes found that physical activity
induces a statistically significant decline of free testosterone, androstenedione, dehydroepiandrosterone–sulfate and
adiposity markers, while a significant increase of SHBG was observed.
Conclusions: Although the effect is relatively modest, physical activity induces a decrease in circulating sex
hormones and this effect is not entirely explained by weight loss. The findings emphasize the benefits of physical
activity for women.
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Introduction
The practice of regular physical activity is recommended
worldwide by different public health agencies [1] for pri-
mary or secondary prevention of many health problems,
including cancers [2, 3]. In particular, physical activity is
associated with a 25 % reduction in the average risk of
breast cancer among women [4], and this protective ef-
fect appears to be independent of menopausal status [5].
Many interrelated biological mechanisms may underlie
this association, such as the effect of physical activity on
glucose metabolism, inflammation, immune function,
and sex hormones [6]. Indeed, endogenous sex hor-
mones, particularly estrogens, seem to be involved in the
initiation, promotion, and progression of tumors [7].
Prolonged exposure to high endogenous hormone levels
is considered one of the main risk factors for female
breast cancer [8–10], with a relative risk of 2.00 (95 %
confidence interval (CI): 1.47–2.71) for postmenopausal
women with the highest estradiol levels [10]. Several ob-
servational studies have found an inverse association be-
tween physical activity and circulating estrogen levels
[11, 12]. This effect may be mediated by the decrease in
fat mass [13], the main source of estrogens in postmeno-
pausal women. It may also be mediated by the disrup-
tion of the menstrual cycle before menopause [14],
especially when exercise is associated with low energy
intakes. However, the assessment of the exposure to
physical activity remains imprecise, because it is gener-
ally only possible to measure it in naturally living sub-
jects using questionnaires [4, 15].
Sex hormones levels could be an objective marker for
evaluating the level and the effectiveness of exposure to
physical activity, and for specifying the type and dose of
appropriate physical activity. If physical activity is shown to
have an effect on sex hormones levels, the present system-
atic review would also clarify one of the biological mecha-
nisms linking physical activity to breast cancer risk. The
objective of this systematic review of randomized controlled
trials is to determine the effect of physical activity on
healthy women’s sex hormone levels, according to the type,
modality, intensity, and duration of physical activity, and
according to the women’s weight and hormonal status.
Methods
A systematic review of randomized controlled trials,
with meta-analysis where possible, was performed fol-
lowing a pre-established protocol and in accordance
with the method described in the Cochrane Handbook
for Systematic Reviews of Interventions [16].
Criteria for considering studies for this review
Types of studies
Any randomized controlled trial that assessed the effects
of physical activity or exercise interventions on sex
hormones in women was considered, regardless of the
modality, type, intensity, or duration of the intervention.
Crossover trials were considered eligible, but only the re-
sults from the first phase were eligible for inclusion in
the quantitative analysis, as an intervention could lead
to long-term effects. No restrictions were applied re-
garding the language or the publication type (articles,
short reports, and abstracts).
Types of participants
Adult cancer-free women were eligible, regardless of
hormonal group (premenopausal, perimenopausal, or
postmenopausal) and body mass index (BMI; normal
weight, overweight, or obese). Age, weight, and hormo-
nal status were considered as defined by the studies. No
participants were excluded based on ethnicity.
Types of interventions
Trials that compared a physical activity intervention
with no treatment, or with any other treatments or pro-
cedures, were included. Physical activity interventions
included: physical exercise of any type, modality, inten-
sity, and duration, as well as lifestyle interventions that
included exercise (i.e., exercise advice); with or without
diet or other cointervention. Trials comparing more
than one form of physical activity were also eligible, and
if no definition was provided by the authors, the less in-
tense intervention was considered the control group. No
restriction was applied regarding who administered the
intervention (physical activity professionals, health pro-
fessionals, or researchers).
Types of outcome measures
The primary outcomes were circulating concentrations
of total and free estradiol.
The secondary outcomes were circulating concentra-
tions of the other estrogens (estrone and estriol), andro-
gens (testosterone and its derivatives, androstenedione
and dehydroepiandrosterone (DHEA)), sex hormone
binding globulin (SHBG), urinary concentrations of sex
steroid metabolites, anthropometric factors (weight,
BMI, and other measures of adiposity), hormonal func-
tion (menstrual regularity and cycle length, or meno-
pausal symptoms – that is, hot flushes or night sweats),
and any side effects of exercise interventions.
The effect of intervention on the primary and second-
ary outcomes was estimated using the measurements
obtained after intervention and/or the variation observed
after intervention (the differences between the values
obtained before and after intervention).
Search methods for identification of studies
An electronic search of randomized controlled trials was
conducted in MEDLINE (via PubMed), EMBASE, and
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CENTRAL (Cochrane Central Register of Controlled
Trials) from inception to December 2014 (see Additional
file 1: Table S1). Search strategies were developed for
each of these databases with text words and index terms
related to the population, intervention, and sex hor-
mones, using appropriate filters for randomized trials on
MEDLINE and EMBASE [16]. No language or publica-
tion date restrictions were applied. The reference lists of
relevant reviews as well as the included studies were
scanned.
Data collection and analysis
Selection of studies
The references identified by the search strategy were
reviewed by one author (KE-I) in a two-step process: the
title and abstract of each study were screened to exclude
the obviously noneligible studies; and the full text of
retained articles was examined and subjected to evalu-
ation using the predefined eligibility criteria. Whenever
required, a second review author (CD) was consulted.
When required, further information was sought from
the authors by email.
Data extraction
Data extraction was performed using an exhaustive stan-
dardized and piloted form designed for this review and
tested on a reference publication by one review author
(KE-I). Information about the study (eligibility criteria,
sample size, and methodology), participant characteristics
(age, ethnicity, unhealthy behaviors, hormonal group,
BMI, hormonal derivatives use, type and level of habitual
physical activity, diet, and habitual energy intake), the de-
scription of the intervention, co-interventions, and
comparators, and different quality evaluation criteria (se-
quence generation, allocation concealment, blinding of
participants and personnel, blinding of outcome assess-
ment, incomplete outcome data, selective reporting bias,
and other sources of bias) were collected. The study defin-
ition of each characteristic or variable retained was re-
corded. In the case of multiple publications related to the
same study, the publication reporting the outcomes of
interest to the present review or the publication with the
longer term follow-up of these outcomes was considered
as the reference, and information was supplemented by
secondary publications as required. The data were ex-
tracted twice over the course of several days to ensure
their quality.
Assessment of risk of bias in retained studies
The assessment of the risk of bias was performed twice
by a review author (KE-I) using the Cochrane risk of
bias assessment tool [16], both for the risk of bias in
each study and for the overall risk of bias across studies.
When required, a second reviewer (CD) was consulted.
Sensitivity analyses were planned to explore the impact
of different levels of risk of bias on the overall interven-
tion effect.
Assessment of heterogeneity
Differences between studies, including intervention
characteristics (differences in modality, type, intensity,
and duration), presence or absence of cointervention,
and participants’ characteristics before (BMI and hormo-
nal status) and after (weight loss) intervention, were
considered for subgroup analysis.
Measures of intervention effect and data synthesis
A quantitative synthesis of data for the comparison “Any
intervention that includes physical activity” versus “Any
intervention that does not include physical activity”
was conducted with RevMan 5.3 software (Cochrane
Review Manager Version 5.3; Nordic Cochrane Centre,
Cochrane Collaboration, Copenhagen, Denmark).
The intervention effect on circulating concentrations
of total and free estradiol, and most other secondary
outcomes, was treated as a continuous variable. The data
were extracted first as reported by the studies, and then
transformed as required [16]. When required, the values
were extracted from graphs using the Plot-digitizer soft-
ware http://plotdigitizer.sourceforge.net/, and standard
deviations were derived from standard errors or CIs
using the RevMan software. The mean difference (MD)
between the intervention groups was calculated using
the values obtained at the end of follow-up. When the
values at the end of follow-up were not reported, the
value of the observed change after the intervention
(MDs before–after intervention) for each group was
used [16]. This combination of measures at the end of
follow-up and measures of change is based on the as-
sumption of comparability of baseline measures for the
two groups provided by randomization. When the out-
come was assessed at different time points during the
same study, only end-of-study results were used. Either
arithmetic or geometric means were used, whichever
was reported by the majority of studies. For instance, the
majority of studies reported arithmetic means of total
estradiol, and therefore arithmetic means were used to
compile data and the reported geometric means were
transformed into the arithmetic form. For free estradiol,
the majority of studies reported geometric means; thus,
geometric means were used and the arithmetic means
were transformed. The transformation from one form to
the other was performed using the first method de-
scribed by Higgins et al. [17]. Finally, the units were con-
verted to those reported by the majority of studies. For
the main comparison, if multiple intervention and/or
control groups were compared in the same study, the re-
spective groups were combined in pairs with RevMan
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software or considered separately when the distinction
was relevant.
The inverse-variance method was used to combine
data from different studies, using a random effects
model to account for both random error and real differ-
ences in populations and interventions between studies
(variability within and between studies). The overall ef-
fect was expressed as the MD between the two groups.
The standardized mean difference (SMD) was used when
the measurement scales between the different studies
could not be corrected by the conversion into a single
unit of measurement, suggesting an error in the unit re-
ported or a difference in the methods used for measure-
ments [16]. Statistical heterogeneity was assessed by the
I2 test, with I2 > 50 % or greater indicating the presence
of substantial heterogeneity [18]. The predefined sub-
group analysis and sensitivity analysis were performed
regardless of the value of I2. The overall risk of bias
across studies and the presence of potential publication
bias (funnel plot method) were evaluated [16, 19]. A
statistical significance level of 5 % was applied to all
analyses.
Results
Results of the search
A total of 9296 references were retrieved by electronic
search, of which 42 were eligible, including two ongoing
studies [20, 21] (Fig. 1). For six studies, the data were
not suitable for quantitative analysis and were not in-
cluded (see Additional file 1: Table S2). Eighteen studies
were included in the meta-analysis of the primary out-
come, circulating estradiol concentrations.
Description of studies
Characteristics of included studies by hormonal groups
are summarized in Table 1 and are described in Table S3
(see Additional file 1). The 40 included studies were
published between 1994 and 2014 and had randomized
between 12 and 439 participants (median = 47 partici-
pants). Ten studies were conducted on premenopausal
eumenorrheic women [22–32], one study on perimeno-
pausal women [33], 13 studies on postmenopausal women
[21, 34–53], and 12 studies on women with polycystic
ovary syndrome (PCOS) [54–67]. One study did not spe-
cify the hormonal status of participants [68], and one
study was conducted on perpartum women [69] and two
studies on postpartum women [70, 71]. The mean age of
participants varied between 15.5 and 71.0 years; the mean
BMI varied between 19.9 and 39.0 kg/m2.
Risk of bias in retained studies
Because the nature of the intervention precluded blind-
ing participants and personnel administering the inter-
vention, all studies were considered to be at high risk of
performance bias (Additional file 1: Figure S1). Since this
criterion does not discriminate between studies, it was
not considered in the assessment of the overall risk of
bias for each study.
Overall, the risk of bias of the included studies was
unclear, with only two studies judged to be at low risk of
bias [40, 41, 48, 49].
Effects of interventions
Primary outcomes
– Total estradiol: 21 studies evaluated circulating
concentrations of total estradiol (Fig. 2). Data from
three studies [31, 42, 53] were not included in the
meta-analysis (incomplete or unsuitable data; see
Additional file 1: Table S2). The overall effect of in-
terventions including physical activity was a decrease
of total estradiol concentrations (n = 18, SMD =
−0.12, 95 % CI: −0.20 to −0.03, I2 = 0 %). Subgroup
analyses indicated that this effect was more pro-
nounced when studies did not include a cointerven-
tion, when the intervention group was compared
with a nonintervention group, when participants
were overweight (baseline BMI between 25 and
30 kg/m2), and when the intervention resulted in
substantial weight loss. This effect was particularly
noticeable for resistance exercise, high-intensity ex-
ercise, exercise performed 3–5 hours per week, for
interventions that included supervised and nonsu-
pervised sessions, and for exercise performed in
group sessions (see Additional file 1: Table S4). The
only study reporting a statistically significant inter-
vention effect was judged to be at low bias risk [40,
41], and when excluded the overall effect was no
longer significant (SMD = −0.06, 95 % CI: −0.16
to 0.03, I2 = 0 %). The funnel plot was roughly
symmetrical, suggesting a low risk of publication
bias (Additional file 1: Figure S2).
– Free estradiol: five studies evaluated circulating
concentrations of free estradiol (Fig. 2).
Interventions including physical activity resulted in
an overall decrease of free estradiol concentrations
(n = 5, SMD = −0.20, 95 % CI: −0.31 to −0.09, I2 =
0 %). None of these studies included a
cointervention or resistance exercise. The observed
effect was more pronounced when the intervention
group was compared with a nonintervention group,
when the participants’ BMI was less than 30 kg/m2,
and for interventions involving high-intensity exer-
cise. This effect seemed to be independent of hor-
monal group, weight loss after intervention, amount
of exercise per week, and intervention modality (see
Additional file 1: Table S4). With the exclusion of
Friedenreich et al.’s study [40, 41], the overall effect
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Fig 1 Flow diagram according to Preferred Reporting Items of Systematic Reviews and Meta-Analyses, with modifications
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remained significant (SMD = −0.17, 95 % CI: −0.30
to −0.04, I2 = 0 %). However, a gap in the left bottom
corner of the funnel plot graph may indicate a sub-
stantial risk of bias (Additional file 1: Figure S3).
Secondary outcomes
– Other estrogens: the overall effect on estrone
circulating concentrations was not significant (n = 4,
MD = −1.67, 95 % CI: −3.62 to 0.28, I2 = 0 %). Few
studies reported the effect on the other estrogen and
estrogen metabolites, and the overall effect for each
of them was not significant (Table 2).
– Androgens: 26 studies reported the effect on
circulating concentrations of total testosterone, of
which five were not suitable for quantitative
synthesis (see Additional file 1: Table S2). The
funnel plot was roughly symmetrical (Figure not
shown) and the overall effect was a nonstatistically
significant decrease of total testosterone (n = 21,
MD = −1.36, 95 % CI: −3.83 to 1.11, I2 = 61 %).
Significant effects were observed for free
testosterone (n = 9, MD = −0.18 pg/ml, 95 % CI:
−0.29 to −0.07, I2 = 0 %), androstenedione (n = 7,
MD = −33.87 pg/ml, 95 % CI: −64.44 to −3.29, I2
= 9 %), and DHEA sulfate (n = 8, MD =
−0.31 μmol/l, 95 % CI: −0.57 to −0.06, I2 = 0 %).
These effects seemed to be independent of
hormonal group, BMI at baseline, and weight loss
after intervention (see Additional file 1: Tables S5
and S6). The effect on free testosterone was
slightly more pronounced for interventions with
high-intensity exercise and for resistance exercise.
The effect on androstenedione was more notice-
able for supervised exercise (see Additional file 1:
Table S6). The effect on DHEA was not signifi-
cant (n = 4, MD = −0.08 ng/ml, 95 % CI: −0.50 to
0.35, I2 = 0 %).
– SHBG: 19 studies reported the effect on SHBG, of
which five were not included in quantitative
Table 1 Summary characteristics of eligible studies (n = 40)
Participants
– Number of randomized participants: 12–439
– Mean age: 15.5–71.0 years
– Mean BMI: 19.9–39.0 kg/m2
– Hormonal groups:
– Pre-menopausal: n = 10
– Peri-menopausal: n = 1
– Post-menopausal: n = 13
– Polycystic ovary syndrome (PCOS): n = 12
– Per-partum: n = 1
– Post-partum: n = 2
– Unspecified: n = 1
Interventions
– Type of exercise:
– Endurance: n = 17
– Resistance: n = 6
– Endurance and resistance: n = 11
– Yoga/Tai chi: n = 2
– Free choice or education to exercise: n = 4
– Modality
– Supervision/monitoring
– Direct or indirect supervision ±monitored
exercise: n = 25
– Monitored only exercise: n = 3
– Mix of supervised and not supervised
exercises: n = 4
– No supervision: n = 5
– Unknown: n = 3
– Group sessions:
– Exercise within group sessions: n = 5
– Unknown: n = 35
– Intensity:
– Light: n = 1
– Moderate: n = 9
– High: n = 19
– Unknown: n = 11
– Frequency:
– <3 days/week: n = 5
– 3 to <5 days/week: n = 21
– ≥5 days/week: n = 10
– Unknown: n = 4
– Total duration:
– <3 months: n = 2
– 3 to <6 months: n = 20
– 6 to <12 months: n = 9
– ≥12 months: n = 9
Table 1 Summary characteristics of eligible studies (n = 40)
(Continued)
– Co-intervention:
– No co-intervention: n = 23
– Diet: n = 12
– Other: n = 8
Comparators
– No intervention: n = 19
– Diet: n = 6
– Other interventions: n = 19
BMI Body Mass Index, n number of studies
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synthesis. The overall effect was a statistically
significant increase in SHBG concentrations (n = 14,
MD = 3.93 nmol/l, 95 % CI: 0.98–6.87, I2 = 75 %).
The analysis of the different subgroups indicated
that the observed effect mainly reflected the effect in
the PCOS hormonal group (n = 8, MD = 6.76 nmol/l,
95 % CI: 5.56–7.96, I2 = 77 %) (see Additional file 1:
Table S6). A gap in the bottom-left corner of the
funnel plot graph was observed, indicating some risk
of bias (Figure not shown).
– Anthropometric factors: overall, physical activity
interventions resulted in statistically significant
decreases in body weight, BMI, total fat mass,
percent fat mass, and waist circumference (Table 2).
– Hormonal function: the data from the 17 studies
reporting hormonal function were not suitable for
quantitative synthesis. Overall, there was no
significant change in menstrual cycle length of
premenopausal women (3 studies) [25, 27, 28]. An
improvement in the regularity or the frequency of
the menstrual cycle and ovulatory parameters was
observed among PCOS participants (11 studies). For
postmenopausal women (two studies), there was no
significant change in menopausal symptom
occurrence [36, 49].
– Side effects: of 13 studies evaluating intervention side
effects, seven did not report side effects related to
exercise. One out of three studies [36, 48, 71]
reported a significant decrease of bone mineral
density and a nonsignificant increase of
musculoskeletal injuries [36].
Discussion
The present systematic review and meta-analysis
based on randomized controlled trials conducted among
healthy women demonstrates a significant decrease
in total and free circulating estradiol concentrations
induced by physical activity, a finding that confirms
the associations reported in observational studies
[11–14, 72–75]. Even though the studies reporting
the effect of exercise on free estradiol represent a
small part of those reporting total estradiol, the effect
of exercise was more obvious for free estradiol than
for total estradiol. This effect seems to be independent
of menopausal status and was observed in nonobese
women.
Fig. 2 Forest plot of comparison “Any intervention that includes physical activity” vs. “Any intervention that does not include physical activity”.
Outcome: total and free estradiol circulating concentrations. CI confidence interval, IV inverse variance, SD standard deviation, Std. Mean Difference
standardized mean difference
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The observation that the decrease in total estradiol
was related to weight loss after intervention, whereas the
decrease in free estradiol was not, suggests that the ef-
fect of exercise on estradiol is not mediated solely by
weight loss and may reflect the sequestration of estradiol
by increasing levels of binding proteins, as was observed
with SHBG levels. Similarly, there was a significant de-
crease in free testosterone but not in total testosterone.
Except for the type of exercise, the conditions associated
with the effect on total estradiol—that is, resistance ex-
ercise, high-intensity exercise, exercise performed for 3–
5 hours per week—are also associated with weight loss.
On the other hand, the effect of exercise modality
(supervision and group sessions) indicates potential con-
founding and performance biases. However, it should be
kept in mind that subgroup analyses are observational
by nature [16] and that a major limitation for these types
of interventions is the risk of performance bias. Some
studies attempted to prevent this problem by administer-
ing a minimal exercise or light conditioning intervention
to the comparator group. That can still be insufficient to
overcome the effect of supervision and direct interaction,
especially when continuous prompting is needed to main-
tain strenuous effort. Moreover, lack of adherence may be
a problem in this type of intervention, which may negate
the benefits of randomization and introduce a selection
bias. In particular, the “intent-to treat” analysis is seldom
really achieved and the reported values are those obtained
from the participants still in the study at the end. Another
problem is the social interactions introduced by group-
session exercise that can potentially confound the ob-
served associations. Therefore, the overall risk of bias
within and across the included studies is unclear.
The strengths of this systematic review include the ex-
tensive and highly sensitive search strategy used to re-
trieve as many relevant studies as possible, and the pre-
established protocol that followed procedures outlined
in the Cochrane Handbook for Systematic Reviews of In-
terventions [16]. Limitations include the noninclusion of
all eligible studies because of unsuitable data and the
lack of high-quality evidence, as indicated by the unclear
overall risk of bias. However, the observed effect on the
Table 2 Meta-analysis of secondary outcomes
Outcome or subgroup Studies (n) Participants (n) Effect estimate 95 % CI I2 (%)
Other estrogens (mean difference)
Estrone (pg/ml) 4 973 −1.67 −3.62, 0.28 0
Estrone sulfate (ng/ml) 2 393 −0.02 −0.19, 0.14 0
Estriol (NR) 1 79 123.90 −249.69, 497.49 NA
Estrogens – not otherwise specified (pg/ml) 2 89 27.80 −9.76, 65.36 94
Estrogen metabolites (standardized mean difference)
2-OHE1 3 512 −0.03 −0.20, 0.15 0
16α-OHE1 3 512 0.03 −0.15, 0.20 1
Total estrogen metabolites concentration (2-OHE1 + 16α-OHE1) 1 32 0.37 −0.33, 1.07 NA
2-OHE1:16α-OHE1 ratio 2 195 −0.08 −0.36, 0.21 0
Androgens (mean difference)
Total testosterone (ng/dl) 21 1939 −1.36 −3.83, 1.11 61
Free testosterone (pg/ml) 9 1369 −0.18 −0.29, −0.07 0
Androstenedione (pg/ml) 7 1187 –33.87 −64.44, −3.29 9
DHEA (ng/ml) 4 304 −0.08 −0.50, 0.35 0
DHEA sulfate (μmol/l) 8 697 −0.31 −0.57, −0.06 0
Sex hormone binding protein (mean difference) (nmol/l)
14 1634 3.93 0.98, 6.87 75
Anthropometric factors (mean difference)
Body weight (kg) 16 1737 −1.83 −2.86, −0.81 45
Body mass index (kg/m2) 20 1976 −0.45 −0.87, −0.03 65
Total body fat (kg) 10 1552 −2.11 −3.71, −0.52 92
Percent fat mass (%) 13 1563 −1.28 −1.95, −0.61 54
Waist circumference (cm) 11 1274 −2.23 −2.97, −1.49 34
CI confidence interval, DHEA dehydroepiandrosterone, NA not applicable, NR not reported, OHE1 hydroxyestrone
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different outcomes remains consistent despite the fact
that different studies were involved for each outcome,
which provides some reassurance about our conclusions.
Considering that the study with the largest sample size
among studies which were not included yielded nonsig-
nificant declines in sex hormones concentrations [42],
the true effect of physical activity on sex hormones
might be slightly underestimated. Finally, the effect of
physical activity on circulating sex hormones is relatively
modest, and probably not clinically significant. The
amount of circulating sex hormones may not necessarily
reflect their effects on target tissues, and physical activity
may still have an effect on sex hormone function by
modulating target-tissue sensitivity to these hormones.
Conclusions
In the last 20 years, numerous randomized trials with
physical activity interventions targeting women have
been conducted. To the best of our knowledge, this is
the first systematic review and meta-analysis of such tri-
als aimed at determining the effect of physical activity
on sex hormone levels. Overall, physical activity induces
a decrease in circulating sex hormones. Although differ-
ent studies were involved for the different outcomes we
considered, the results for overall meta-analysis and sub-
group analyses were consistent. Even if it appears that
the effect of physical activity is not completely accurately
reflected by measures of circulating sex hormones, phys-
ical activity is a safe intervention with undeniable bene-
fits for women, regardless of menopausal status and
weight loss induced by exercise.
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